It presents compelling evidence that PTPN12 modulates cell proliferation by affecting the Hippo effector proteins YAP and TAZ, suggesting a potential strategy for treating breast cancer patients with compromised PTPN12. This evidence concerns the gene PTPN12 and breast cancer.